At Shorla Pharma we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population.

Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments.

Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care.

Working with world renowned key opinion leaders and first in class research scientists our team merge experience and innovation to solve real world clinical problems. By integrating these innovative solutions into effective oncology treatments patients’ lives are greatly improved.